Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)
China · Delayed Price · Currency is CNY 12.61
-0.15 (-1.18%)
Sep 11, 2026, 3:04 PM CST
SHE:300122 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 8,054 | 8,958 | 26,049 | 52,918 | 38,264 | 30,652 |
Revenue Growth | -36.68% | -65.61% | -50.77% | 38.30% | 24.83% | 101.79% |
Gross Profit Gross Profit Growth | -13,327 | -12,916 | 7,083 | 13,932 | 12,746 | 14,925 |
Operating Income Operating Income Growth | -17,358 | -17,181 | 2,256 | 9,206 | 8,698 | 11,924 |
Net Income Net Income Growth | -14,925 | -14,723 | 1,972 | 8,070 | 7,539 | 10,209 |
Earnings Per Share EPS Growth | -6.24 | -6.15 | 0.82 | 3.36 | 3.14 | 4.25 |
EPS Growth | - | - | -75.51% | 7.04% | -26.15% | 209.23% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Biochemical Product Biochemical Product Growth | 8,868 | 25,824 | 52,914 | 38,260 | 30,629 |
Unallocated Others Unallocated Others Growth | 90.42 | 225.35 | 4.08 | 3.85 | 23.46 |
Total Total Growth | 8,958 | 26,049 | 52,918 | 38,264 | 30,652 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 2,105 | 2,626 | 2,717 | 6,341 | 2,622 | 4,308 |
Total Debt Total Debt Growth | 10,188 | 12,287 | 13,257 | 3,035 | 2,033 | 817.76 |
Net Cash (Debt) Net Cash Growth | -8,083 | -9,662 | -10,540 | 3,305 | 588.94 | 3,490 |
Net Cash Growth | - | - | - | 461.19% | -83.13% | - |
Net Cash Per Share Net Cash Per Share Growth | -3.38 | -4.04 | -4.40 | 1.38 | 0.25 | 1.45 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 5,519 | 5,167 | -4,224 | 8,996 | 1,989 | 8,508 |
Capital Expenditures CapEx Growth | -450.26 | -619.19 | -1,201 | -1,134 | -1,453 | -1,932 |
Free Cash Flow Free Cash Flow Growth | 5,068 | 4,548 | -5,425 | 7,862 | 535.93 | 6,575 |
Free Cash Flow Growth | - | - | - | 1367.02% | -91.85% | 146.30% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Gross Margin | -165.47% | -144.17% | 27.19% | 26.33% | 33.31% | 48.69% |
Operating Margin | -215.53% | -191.79% | 8.66% | 17.40% | 22.73% | 38.90% |
Pretax Margin | -219.43% | -195.26% | 8.30% | 17.65% | 22.78% | 38.92% |
Profit Margin | -185.33% | -164.35% | 7.57% | 15.25% | 19.70% | 33.30% |
FCF Margin | 62.93% | 50.77% | -20.83% | 14.86% | 1.40% | 21.45% |
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.200 | 0.800 | 0.333 | 0.400 |
Dividend Per Share Growth | -75.00% | 140.02% | -16.68% | 20.01% |
Dividend Yield | 0.76% | 1.36% | 0.60% | 0.51% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 31.92 | 18.17 | 18.64 | 19.53 |
Forward PE | - | 42.16 | 14.60 | 15.39 | 19.63 | 21.81 |
P/FCF Ratio | 6.03 | 9.93 | - | 18.65 | 262.21 | 30.32 |
PS Ratio | 3.79 | 5.04 | 2.42 | 2.77 | 3.67 | 6.50 |